The acquisitions are small relative to CAH's $53.5B market cap, but they signal continued investment in the at-Home Solutions segment. Monitor integration progress and any impact on Q1 FY27 guidance. The stock may see a modest positive reaction given the accretive nature and strategic fit.
Price Chart
Executive Summary
Cardinal Health announced two tuck-in acquisitions totaling $360M in cash to expand its at-Home Solutions business, acquiring AdaptHealth's diabetes unit and Strive Medical. The deals are small relative to CAH's $53.5B market cap and are expected to be accretive to non-GAAP EPS within 12 months, but the strategic impact is modest and routine for a diversified healthcare distributor.
Key Financial Metrics
Key Facts
- Combined acquisition price of approximately $360 million in cash, subject to working capital adjustments.
- Acquires AdaptHealth's Diabetes Health business (serving >225,000 patients annually) and Strive Medical (serving >20,000 patients, specializing in urology, wound care, ostomy, and incontinence).
- Expected to be accretive to non-GAAP EPS within the first 12 months post-close.
- Transactions are subject to customary closing conditions and regulatory approvals.
- Builds on the prior acquisition of Advanced Diabetes Supply (ADS) and the at-Home Solutions platform.
Financial Impact
Two tuck-in acquisitions for $360M total, expanding home care capabilities in diabetes and urology. Expected to be accretive to non-GAAP EPS within 12 months.
Risk Factors
- Integration risk from folding two distinct businesses into at-Home Solutions platform.
- Regulatory approval delays or conditions could alter deal terms.
- Competitive pressure in home care distribution may limit margin expansion.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302829980 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 20, 2026 6w ago | Insider Cluster | $228.46 $225.38 | ▼ −1.35% | ▼ −1.35% | $227.72 (−0.32%) |
Aug 20, 2026 6w ago | Insider Cluster | $228.46 $225.38 | ▼ −1.35% | ▼ −1.35% | $227.72 (−0.32%) |
Aug 20, 2026 6w ago | Insider Cluster | $228.46 $225.38 | ▼ −1.35% | ▼ −1.35% | $227.72 (−0.32%) |
Aug 11, 2026 7w ago | 8-K | $240.26 $239.92 | ▼ −0.14% | ▲ +0.92% | $227.72 (−5.22%) |
Aug 11, 2026 7w ago | 8-K | $240.26 $239.92 | ▼ −0.14% | ▲ +0.92% | $227.72 (−5.22%) |
Aug 5, 2026 8w ago | 8-K | $239.23 $245.49 | ▲ +2.62% | ▲ +3.22% | $227.72 (−4.81%) |
Jul 20, 2026 10w ago | Press Release | $227.09 $234.98 | ▲ +3.47% | ▲ +0.91% | $227.72 (+0.28%) |
Mar 5, 2026 30w ago | 8-K | $215.96 $214.02 | ▼ −0.90% | ▲ +2.89% | $227.72 (+5.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access